<p><h1>Mumps Vaccine Market Size: Growth Outlook from 2024 to 2031, projecting at Market's Trends Analysis by Application, Regional Outlook, and Revenue</h1></p><p><strong>Mumps Vaccine Market Analysis and Latest Trends</strong></p>
<p><p>The Mumps Vaccine is a preventive immunization designed to protect individuals against mumps, a contagious viral infection that primarily affects the salivary glands. The vaccine contains a weakened form of the mumps virus that stimulates the immune system to produce antibodies, providing immunity against future infections. It is administered through a routine childhood vaccination schedule and is recommended for both children and adults who have not been previously vaccinated or have not had a mumps infection.</p><p>The Mumps Vaccine Market has been experiencing steady growth due to increasing awareness about the benefits of immunization and efforts by governments and healthcare organizations to control mumps outbreaks. The market is also driven by the growing number of initiatives to improve vaccine coverage rates across various regions. Additionally, the rising demand for combination vaccines that provide protection against multiple diseases, including mumps, has fueled market growth.</p><p>Furthermore, the Mumps Vaccine Market has witnessed advancements in vaccine technology, such as the development of more effective and safer vaccines. These advancements have led to the introduction of highly efficient vaccines that provide long-lasting immunity with fewer side effects. Moreover, the emergence of new players in the market has intensified the competition, leading to the development of innovative vaccines.</p><p>The market is expected to continue its growth trajectory during the forecast period, with a projected CAGR of 10.9%. Factors such as increasing government initiatives to eradicate mumps, growing investments in research and development, and rising incidence of mumps outbreaks are anticipated to contribute to market growth. Moreover, the development of combination vaccines and the expansion of vaccination programs in developing countries are expected to offer lucrative opportunities for market players. Overall, the Mumps Vaccine Market is poised to witness significant growth in the coming years.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1881902">https://www.reliableresearchreports.com/enquiry/request-sample/1881902</a></p>
<p>&nbsp;</p>
<p><strong>Mumps Vaccine Major Market Players</strong></p>
<p><p>The global mumps vaccine market is highly competitive, with numerous players operating in the industry. Some of the key market players include MedImmune (a subsidiary of AstraZeneca), Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited, Emergent BioSolutions, GlaxoSmithKline, Panacea Biotec Ltd., Biological E Limited, Bharat Biotech Ltd., Novavax, Inc., Novartis, Sinovac Biotech, Ltd., Incepta Vaccine Limited, Valneva SE, VBI Vaccines, and PT Bio Farma.</p><p>MedImmune, a prominent player in the market, has a strong presence in the mumps vaccine segment. In 2019, the company launched its mumps vaccine called Priorix. The company has been focusing on extensive research to develop new and improved mumps vaccine formulations. MedImmune's market growth has been driven by its commitment to innovation and strong partnerships with government bodies and healthcare organizations.</p><p>Merck & Co., Inc. is another major player in the mumps vaccine market. The company offers the M-M-R II vaccine, which provides protection against measles, mumps, and rubella. Merck has been investing in research and development activities to develop new vaccine formulations and improve its existing products. The company's market growth can be attributed to its strong brand reputation and wide distribution network.</p><p>GlaxoSmithKline (GSK) is also a significant player in the market. GSK offers the Priorix-Tetra vaccine, which provides protection against measles, mumps, rubella, and varicella (chickenpox). GSK has a strong global presence and has been focusing on expanding its market reach through strategic collaborations and partnerships. The company's market growth is driven by its robust vaccine portfolio and strong financial performance.</p><p>In terms of market size, the mumps vaccine market was valued at approximately $952 million in 2020 and is expected to reach $1.4 billion by 2027, with a compound annual growth rate (CAGR) of 5.6% during the forecast period. However, specific sales revenue figures for the mentioned companies are not available in the provided information.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Mumps Vaccine Manufacturers?</strong></p>
<p><p>The mumps vaccine market has witnessed significant growth in recent years and is expected to continue its upward trajectory in the foreseeable future. The increasing prevalence of mumps globally, coupled with rising awareness about vaccination and government initiatives promoting immunization programs, has fueled the market growth. Moreover, the introduction of advanced vaccines and ongoing research and development activities are further contributing to the expansion of the market. The future outlook for the mumps vaccine market is highly optimistic, with high demand expected from both developed and developing regions due to the growing concerns regarding infectious diseases and the need for effective preventive measures.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1881902">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1881902</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Mumps Vaccine Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Child</li><li>Adult</li></ul></p>
<p><p>The mumps vaccine market can be classified into Child and Adult markets. The Child market refers to the segment that caters to children who are typically recommended to receive the vaccine at a young age to protect them from mumps. On the other hand, the Adult market targets individuals who did not receive the vaccine during childhood or require booster shots due to waning immunity. This market segment aims to ensure adults remain protected against mumps and prevent potential outbreaks. Both markets contribute to the overall demand for mumps vaccines.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1881902">https://www.reliableresearchreports.com/purchase/1881902</a></p>
<p>&nbsp;</p>
<p><strong>The Mumps Vaccine Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals Pharmacies</li><li>Retail Pharmacies</li></ul></p>
<p><p>The mumps vaccine market is utilized in various healthcare settings, including hospitals and retail pharmacies. Hospitals play a critical role in administering vaccines to patients, ensuring easy accessibility and inclusion in vaccination programs. Retail pharmacies also contribute to the distribution of mumps vaccines by making them readily available to the general public. Both settings contribute to increasing vaccination rates, protecting individuals from mumps and reducing the spread of the virus in the community.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Mumps Vaccine Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The global mumps vaccine market is projected to witness significant growth across various regions, including North America (NA), Asia-Pacific (APAC), Europe, the United States (USA), and China. North America is expected to dominate the market with the largest market share percentage valuation, driven by factors such as high incidence of mumps cases and a well-established healthcare infrastructure. APAC region is also anticipated to witness substantial growth, primarily due to increasing awareness about vaccination and rising government initiatives to control mumps outbreaks. Europe is projected to display steady growth, while the USA and China are expected to contribute significantly to the market's expansion.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1881902">https://www.reliableresearchreports.com/purchase/1881902</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1881902">https://www.reliableresearchreports.com/enquiry/request-sample/1881902</a></p>
<p><strong></strong></p>
<p><p><a href="https://github.com/jaidynmorantestelletmjzya/Market-Research-Report-List-1/blob/main/nicotinamide-phosphoribosyltransferase-market.md">Nicotinamide Phosphoribosyltransferase Market</a></p><p><a href="https://medium.com/p/5c6afa0fe6ff/edit">Synthetic & Bio-based Aniline Market</a></p><p><a href="https://medium.com/p/b67252759496/edit">Supported Metal Catalyst Market</a></p><p><a href="https://medium.com/p/e979cd7f1cff/edit">Waterproofing Chemical Market</a></p><p><a href="https://github.com/souheilhilleyweberco461qxfxzd/Market-Research-Report-List-1/blob/main/melanocyte-stimulating-hormone-receptor-market.md">Melanocyte Stimulating Hormone Receptor Market</a></p></p>